P

Plus Therapeutics
D

PSTV

0.27790
USD
-0.02
(-7.21%)
مفتوح الان
حجم التداول
45,435
الربح لكل سهم
-0
العائد الربحي
-
P/E
-0
حجم السوق
4,724,196
أصول ذات صلة
AAPL
AAPL
0.780
(0.39%)
200.080 USD
AMZN
AMZN
1.260
(0.61%)
206.130 USD
CMCSA
CMCSA
0.430
(1.24%)
34.950 USD
DIS
DIS
1.560
(1.41%)
112.530 USD
GOOGL
GOOGL
0.190
(0.11%)
172.580 USD
NFLX
NFLX
15.48
(1.30%)
1,207.07 USD
ROKU
ROKU
1.560
(2.22%)
71.840 USD
T
T
0.180
(0.66%)
27.455 USD
المزيد
الأخبار المقالات

العنوان: Plus Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).